Pacific Wealth Management
Registered adviserRegulatory profile
From Form ADV, the SEC filer profile, 13D/13G type codes and N-CEN, never from the name.
| Rosters | Regulatory AUM | Main clients |
|---|---|---|
| May 2026 to Oct 2026 | $371,941,587 | Individuals and high net worth (100%) |
| Apr 2025 to Apr 2026 | $317,620,996 | Individuals and high net worth (100%) |
| Apr 2024 to Mar 2025 | $269,940,691 | Individuals and high net worth (100%) |
| May 2023 to Mar 2024 | $260,254,707 | Individuals and high net worth (100%) |
| Apr 2023 | $260,254,707 | Individuals and high net worth (100%) |
| Apr 2022 to Mar 2023 | $239,029,977 | Individuals and high net worth (100%) |
Portfolio style
Measured from the filed 13F common-share book for Jun 30, 2026, the newest measured quarter, never from the firm's own description.
Closest benchmark: every 13F filer's combined book, active share 93.0%; sector active share 78.5% against the combined 13F book's sector weights.
Over time 23 measured quarters
How the bands are measured
Style bands measure the filed 13F common-share book each closed quarter, tested in this order. Unknown: under $10,000,000 of valued equity or 5 stocks. Index-like (100+ stocks): active share of 20% or less against the closest benchmark, which is the S&P 500, S&P MidCap 400, S&P SmallCap 600, Russell 1000, Russell 2000, Nasdaq-100 or Dow Jones Industrial Average (weighted by an index-tracking fund's reported holdings or the index's constituents nearest the quarter end, over the names resolved to companies, and only when those are 90%+ of its weight) or every 13F filer's combined book, or index series holding 80%+ of the registered fund assets it advises (N-CEN) and equal to 50%+ of its book. Systematic-like: 500+ stocks, 100%+ annual turnover and a top 10 weight of 25% or less. Concentrated: a top 10 weight of 60%+ or 12 or fewer effective positions. Diversified active: none of these. Turnover is the smaller of buys and sells over average equity value, summed over four quarters: low under 30%, high 100%+. Horizon is the value-weighted number of quarters each position has been held: short under 4, long 12+.
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
20 tracked positions · as of Sep 30, 2026 · Δ vs Jun 30, 2026Portfolio Trend
Sector Breakdown
As of Sep 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 91.3% | $202,599,153 |
| Healthcare | 5.6% | $12,465,714 |
| Technology | 2.9% | $6,435,774 |
| Financial Services | 0.1% | $304,745 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VCIT | VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND | +10,368 | 108,638 | $8,507,441 | |
| EMEQ | Nomura Focused Emerging Markets Equity ETF | +9,970 | 490,243 | $32,196,709 | |
| SPY | Spdr S&P 500 ETF Trust | +586 | 175,280 | $133,673,786 | |
| INTC | Intel Corp | +278 | 40,802 | $4,905,624 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| GOVT | iShares U.S. Treasury Bond ETF | −178,586 | 497,893 | $10,888,919 | |
| IEF | iShares 7-10 Year Treasury Bond ETF | −56,930 | 101,981 | $9,107,923 | |
| HALO | Halozyme Therapeutics, Inc. | −3,217 | 2,184 | $241,113 | |
| ABT | Abbott Laboratories | −974 | 23,009 | $2,273,979 | |
| MSFT | Microsoft Corp | −318 | 963 | $493,922 | |
| AAPL | Apple Inc. | −237 | 1,922 | $640,064 | |
| ABBV | AbbVie Inc. | −229 | 38,039 | $9,950,622 | |
| BRK-B | Berkshire Hathaway Inc | −40 | 612 | $304,745 | |
| VOO | VANGUARD 500 INDEX FUND | −15 | 463 | $324,498 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| SPY |
Spdr S&P 500 ETF Trust
|
Added | 175,280 | $133,673,786 | 60.27% | |
| EMEQ |
Nomura Focused Emerging Markets Equity ETF
|
Added | 490,243 | $32,196,709 | 14.52% | |
| GOVT |
iShares U.S. Treasury Bond ETF
|
Reduced | 497,893 | $10,888,919 | 4.91% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Reduced | 38,039 | $9,950,622 | 4.49% | |
| IEF |
iShares 7-10 Year Treasury Bond ETF
|
Reduced | 101,981 | $9,107,923 | 4.11% | |
| VCIT |
VANGUARD INTERMEDIATE-TERM CORPORATE BOND INDEX FUND
|
Added | 108,638 | $8,507,441 | 3.84% | |
| XLV |
State Street(R) Health Care Select Sector SPDR(R) ETF
|
NEW | 33,577 | $5,655,038 | 2.55% | |
| INTC |
Intel Corp
Technology
|
Added | 40,802 | $4,905,624 | 2.21% | |
| ABT |
Abbott Laboratories
Healthcare
|
Reduced | 23,009 | $2,273,979 | 1.03% | |
| GLD |
Spdr Gold Trust
|
NEW | 3,331 | $1,268,578 | 0.57% | |
| AAPL |
Apple Inc.
Technology
|
Reduced | 1,922 | $640,064 | 0.29% | |
| MSFT |
Microsoft Corp
Technology
|
Reduced | 963 | $493,922 | 0.22% | |
| ONTO |
Onto Innovation Inc.
Technology
|
Held | 1,287 | $396,164 | 0.18% | |
| QLTA |
iShares Aaa - A Rated Corporate Bond ETF
|
Held | 7,499 | $337,380 | 0.15% | |
| DFAW |
Dimensional World Equity ETF
|
NEW | 4,059 | $334,096 | 0.15% | |
| VOO |
VANGUARD 500 INDEX FUND
|
Reduced | 463 | $324,498 | 0.15% | |
| QQQ |
Invesco Qqq Trust, Series 1
|
Held | 412 | $304,785 | 0.14% | |
| BRK-B |
Berkshire Hathaway Inc
Financial Services
|
Reduced | 612 | $304,745 | 0.14% | |
| HALO |
Halozyme Therapeutics, Inc.
Healthcare
|
Reduced | 2,184 | $241,113 | 0.11% | |
| AIQ |
Global X Artificial Intelligence & Technology ETF
|
NEW | 84,913 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.